COMP <GO>
ZTS vs JNJ // REVENUE GROWTH (YOY)
Zoetis Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ZTS 7
— JNJ 7
▲ REVENUE GROWTH (YOY) LEADER: JNJ
LAST: $79.72 (+1.17%) • MKT CAP: $32.56B
revenue-growth
2.30%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
revenue-growth
6.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZTS VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZTS | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.80% | 67.90% | +3.90 | ZTS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 25.70% | 25.50% | +0.20 | ZTS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.3x | 18.5x | -8.20 | ZTS | /valuation <GO> |
| Free Cash Flow Yield | 7.01% | 2.97% | +4.04 | ZTS | /fcf-yield <GO> |
| Operating Margin | 34.40% | 34.70% | -0.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 28.20% | 28.50% | -0.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 2.30% | 6.00% | -3.70 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.53 | 5.59 | -1.06 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.20% | -0.30 | ZTS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.4 | 60.4 | +0.09 | ZTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.08 | -0.09 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.3x | 23.0x | -11.70 | ZTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $32.56B | $662.49B | -$629.93B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZTS REV | JNJ REV | ZTS GROSS % | JNJ GROSS % | ZTS FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.47B | $94.19B | 71.8% | 67.9% | $2.28B | $19.70B |
| FY 2024 | $9.26B | $88.82B | 70.6% | 69.1% | $2.30B | $19.84B |
| FY 2023 | $8.54B | $85.16B | 44.0% | 44.0% | $1.97B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZTS // BETA 0.99
JNJ // BETA 1.08